171 related articles for article (PubMed ID: 33545802)
41. Lenvatinib complementary with radioiodine therapy for patients with advanced differentiated thyroid carcinoma: case reports and literature review.
Sheu NW; Jiang HJ; Wu CW; Chiang FY; Chiou HC; Hsiao PJ
World J Surg Oncol; 2019 May; 17(1):84. PubMed ID: 31103041
[TBL] [Abstract][Full Text] [Related]
42. [A Case of Good Quality of Life(QOL)and Favorable Response to Transarterial Chemoembolization(TACE)against Synchronous Multiple Liver Metastases].
Sugimoto K; Sakamoto K; Amemiya K; Tsuchiya Y; Hagiwara T; Matsuzawa H; Makino Y; Motegi S; Kawai M; Ishiyama S; Kamiyama H; Takahashi M; Kojima Y; Tomiki Y; Kuwatsuru R
Gan To Kagaku Ryoho; 2019 Apr; 46(4):730-732. PubMed ID: 31164517
[TBL] [Abstract][Full Text] [Related]
43. [A Case of Metachronous Multiple Liver Metastases of AFP and PIVKA-Ⅱ Producing Gastric Cancer, Responding to Transcatheter Arterial Chemoembolization].
Sawatsubashi T; Nakatsuka H; Nihei K; Takano T
Gan To Kagaku Ryoho; 2020 Feb; 47(2):319-321. PubMed ID: 32381975
[TBL] [Abstract][Full Text] [Related]
44. [A case of advanced gastric cancer with multiple liver, lung, and lymph node metastases treated with S-1, CDDP, and trastuzumab].
Fukuda N; Niki M; Sano M; Ogura R; Wada J
Gan To Kagaku Ryoho; 2014 Sep; 41(9):1167-70. PubMed ID: 25248905
[TBL] [Abstract][Full Text] [Related]
45. Lenvatinib for hepatocellular carcinoma: From preclinical mechanisms to anti-cancer therapy.
Zhao Y; Zhang YN; Wang KT; Chen L
Biochim Biophys Acta Rev Cancer; 2020 Aug; 1874(1):188391. PubMed ID: 32659252
[TBL] [Abstract][Full Text] [Related]
46. Phase 2 study of lenvatinib in patients with advanced hepatocellular carcinoma.
Ikeda K; Kudo M; Kawazoe S; Osaki Y; Ikeda M; Okusaka T; Tamai T; Suzuki T; Hisai T; Hayato S; Okita K; Kumada H
J Gastroenterol; 2017 Apr; 52(4):512-519. PubMed ID: 27704266
[TBL] [Abstract][Full Text] [Related]
47. Interstitial pneumonia suspected during regorafenib administration and exacerbated by subsequent therapy with lenvatinib for unresectable hepatocellular carcinoma.
Kotani K; Enomoto M; Okada M; Yoshida K; Motoyama H; Fujii H; Hagihara A; Uchida-Kobayashi S; Morikawa H; Murakami Y; Tamori A; Kawada N
Clin J Gastroenterol; 2019 Aug; 12(4):355-360. PubMed ID: 31020569
[TBL] [Abstract][Full Text] [Related]
48. [Clinical efficacy and safety analysis of camrelizumab combined with apatinib as a second-line therapy for unresectable hepatocellular carcinoma: a multicenter retrospective study].
Yuan GS; He WM; Hu XY; Li Q; Zang MY; Cheng X; Huang W; Ruan J; Wang JJ; Hou JL; Chen JZ
Zhonghua Gan Zang Bing Za Zhi; 2021 Apr; 29(4):326-331. PubMed ID: 33979958
[No Abstract] [Full Text] [Related]
49. The safety and efficacy of transarterial chemoembolization combined with sorafenib and sorafenib mono-therapy in patients with BCLC stage B/C hepatocellular carcinoma.
Wu FX; Chen J; Bai T; Zhu SL; Yang TB; Qi LN; Zou L; Li ZH; Ye JZ; Li LQ
BMC Cancer; 2017 Sep; 17(1):645. PubMed ID: 28899349
[TBL] [Abstract][Full Text] [Related]
50. [A case report of bi-weekly docetaxel and S-1 combination chemotherapy for gastric cancer with multiple liver metastases and esophageal invasion].
Matsuda S; Takahashi M; Watanabe J; Yabuno T; Mochizuki Y; Kito F; Kunisaki C
Gan To Kagaku Ryoho; 2010 Jul; 37(7):1353-6. PubMed ID: 20647726
[TBL] [Abstract][Full Text] [Related]
51. [A case of advanced gastric cancer with multiple liver metastases successfully treated with TS-1/low-dose CDDP/lentinan combination chemotherapy].
Takahashi T; Fujisaki M; Hirahata S; Maeda D; Tokura H; Ohyama T; Irino T
Gan To Kagaku Ryoho; 2006 Dec; 33(13):2061-3. PubMed ID: 17197754
[TBL] [Abstract][Full Text] [Related]
52. Pulmonary metastasis of hepatocellular carcinoma associated with transarterial chemoembolization.
Liou TC; Shih SC; Kao CR; Chou SY; Lin SC; Wang HY
J Hepatol; 1995 Nov; 23(5):563-8. PubMed ID: 8583145
[TBL] [Abstract][Full Text] [Related]
53. Drug effect analysis of sorafenib combined with transcatheter arterial chemoembolization in the treatment of advanced hepatocellular carcinoma.
Xu X; Meng Q
Pak J Pharm Sci; 2018 Jul; 31(4(Special)):1751-1755. PubMed ID: 30203774
[TBL] [Abstract][Full Text] [Related]
54. [Dendritic cell-cytokine induced killer cell immunotherapy combined with transcatheter arterial chemoembolization for hepatocellular carcinoma: safety and efficacy].
Guo W; Liu L; Wu D
Nan Fang Yi Ke Da Xue Xue Bao; 2014 May; 34(5):674-8. PubMed ID: 24849434
[TBL] [Abstract][Full Text] [Related]
55. Development of a thrombus in the superior mesenteric artery associated with sequential therapy with tyrosine kinase inhibitors for hepatocellular carcinoma.
Nawa T; Katayama K; Kiyota R; Imai T; Abe Y; Hasegawa N; Takada R; Fukutake N; Ikezawa K; Sakakibara M; Fujita M; Ohkawa K
Clin J Gastroenterol; 2020 Apr; 13(2):247-251. PubMed ID: 31317371
[TBL] [Abstract][Full Text] [Related]
56. Transcatheter arterial chemoembolization after stopping sorafenib therapy for advanced hepatocellular carcinoma.
Huang YK; Yen CL; Shiu SI; Lee SW; Chang PY; Yeh HZ; Lee TY
PLoS One; 2017; 12(11):e0188999. PubMed ID: 29190692
[TBL] [Abstract][Full Text] [Related]
57. Lenvatinib plus pembrolizumab in patients with advanced endometrial cancer: an interim analysis of a multicentre, open-label, single-arm, phase 2 trial.
Makker V; Rasco D; Vogelzang NJ; Brose MS; Cohn AL; Mier J; Di Simone C; Hyman DM; Stepan DE; Dutcus CE; Schmidt EV; Guo M; Sachdev P; Shumaker R; Aghajanian C; Taylor M
Lancet Oncol; 2019 May; 20(5):711-718. PubMed ID: 30922731
[TBL] [Abstract][Full Text] [Related]
58. Early changes in ammonia levels and liver function in patients with advanced hepatocellular carcinoma treated by lenvatinib therapy.
Ohya K; Kawaoka T; Namba M; Uchikawa S; Kodama K; Morio K; Nakahara T; Murakami E; Hiramatsu A; Tsuge M; Yamauchi M; Imamura M; Chayama K; Aikata H
Sci Rep; 2019 Aug; 9(1):12101. PubMed ID: 31431642
[TBL] [Abstract][Full Text] [Related]
59. Conventional Versus Small Doxorubicin-eluting Bead Transcatheter Arterial Chemoembolization for Treating Barcelona Clinic Liver Cancer Stage 0/A Hepatocellular Carcinoma.
Kang YJ; Lee BC; Kim JK; Yim NY; Kim HO; Cho SB; Jeong YY
Cardiovasc Intervent Radiol; 2020 Jan; 43(1):55-64. PubMed ID: 31646378
[TBL] [Abstract][Full Text] [Related]
60. [An effective case of arterial infusion therapy of low-dose CDDP and continuous 5-FU for isolated hepatic recurrence of gastric carcinoma].
Akamo Y; Takeyama H; Mohri N; Teranishi F; Ohara E; Kawashima N; Hayakawa T; Fukui T; Tanaka M; Mizuno I; Manabe T
Gan To Kagaku Ryoho; 1999 Oct; 26(12):1945-7. PubMed ID: 10560432
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
